Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1946 1
1947 3
1948 1
1949 2
1951 1
1952 3
1953 1
1954 3
1955 1
1956 1
1958 1
1959 1
1960 1
1961 1
1962 1
1963 1
1964 1
1965 1
1967 2
1969 1
1971 1
1974 1
1975 1
1992 1
1994 2
1995 2
1996 5
1997 4
1998 2
1999 5
2000 2
2001 2
2002 5
2003 6
2004 4
2005 5
2006 6
2007 1
2008 4
2009 9
2010 6
2011 7
2012 5
2013 5
2014 7
2015 5
2016 6
2017 10
2018 9
2019 18
2020 13
2021 15
2022 9
2023 9
2024 6

Text availability

Article attribute

Article type

Publication date

Search Results

208 results

Results by year

Filters applied: . Clear all
Page 1
A phase III, randomized, placebo-controlled study of belimumab, a monoclonal antibody that inhibits B lymphocyte stimulator, in patients with systemic lupus erythematosus.
Furie R, Petri M, Zamani O, Cervera R, Wallace DJ, Tegzová D, Sanchez-Guerrero J, Schwarting A, Merrill JT, Chatham WW, Stohl W, Ginzler EM, Hough DR, Zhong ZJ, Freimuth W, van Vollenhoven RF; BLISS-76 Study Group. Furie R, et al. Among authors: schwarting a. Arthritis Rheum. 2011 Dec;63(12):3918-30. doi: 10.1002/art.30613. Arthritis Rheum. 2011. PMID: 22127708 Free PMC article. Clinical Trial.
Systemic Lupus Erythematosus (SLE) Therapy: The Old and the New.
Basta F, Fasola F, Triantafyllias K, Schwarting A. Basta F, et al. Among authors: schwarting a. Rheumatol Ther. 2020 Sep;7(3):433-446. doi: 10.1007/s40744-020-00212-9. Epub 2020 Jun 2. Rheumatol Ther. 2020. PMID: 32488652 Free PMC article. Review.
Autoantibodies against the chemokine receptor 3 predict cardiovascular risk.
Müller FS, Aherrahrou Z, Grasshoff H, Heidorn MW, Humrich JY, Johanson L, Aherrahrou R, Reinberger T, Schulz A, Ten Cate V, Robles AP, Koeck T, Rapp S, Lange T, Brachaczek L, Luebber F, Erdmann J, Heidecke H, Schulze-Forster K, Dechend R, Lackner KJ, Pfeiffer N, Ghaemi Kerahrodi J, Tüscher O, Schwarting A, Strauch K, Münzel T, Prochaska JH, Riemekasten G, Wild PS. Müller FS, et al. Among authors: schwarting a. Eur Heart J. 2023 Dec 14;44(47):4935-4949. doi: 10.1093/eurheartj/ehad666. Eur Heart J. 2023. PMID: 37941454 Free PMC article.
Efficacy and Safety of Subcutaneous Belimumab in Systemic Lupus Erythematosus: A Fifty-Two-Week Randomized, Double-Blind, Placebo-Controlled Study.
Stohl W, Schwarting A, Okada M, Scheinberg M, Doria A, Hammer AE, Kleoudis C, Groark J, Bass D, Fox NL, Roth D, Gordon D. Stohl W, et al. Among authors: schwarting a. Arthritis Rheumatol. 2017 May;69(5):1016-1027. doi: 10.1002/art.40049. Epub 2017 Apr 7. Arthritis Rheumatol. 2017. PMID: 28118533 Free PMC article. Clinical Trial.
[Infection-triggered arthralgia and arthritis].
Klonowski A, Schwarting A. Klonowski A, et al. Among authors: schwarting a. MMW Fortschr Med. 2020 Feb;162(2):39-42. doi: 10.1007/s15006-020-0104-9. MMW Fortschr Med. 2020. PMID: 32016764 Review. German. No abstract available.
[Experiences and results from Rheuma-VOR].
Schwarting A, Dreher M, Assmann G, Witte T, Hoeper K, Schmidt RE. Schwarting A, et al. Z Rheumatol. 2019 Oct;78(8):743-752. doi: 10.1007/s00393-019-00694-1. Z Rheumatol. 2019. PMID: 31468168 Review. German.
Epigenetic Aspects of Systemic Lupus Erythematosus.
Relle M, Foehr B, Schwarting A. Relle M, et al. Among authors: schwarting a. Rheumatol Ther. 2015 Jun;2(1):33-46. doi: 10.1007/s40744-015-0014-y. Epub 2015 Jun 16. Rheumatol Ther. 2015. PMID: 27747498 Free PMC article. Review.
208 results